Category: Health

OS Therapies CEO Paul Romness and Chief Medical & Scientific Officer Robert Petit at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Senior Research Analyst Ahu Demir, PhD joins Paul and Robert to moderate a Q&A session.

Onconova Therapeutics (ONTX) CEO Steven Fruchtman at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Senior Research Analyst Ahu Demir, PhD joins Steven to moderate a Q&A session.

Ocugen (OCGN) CEO Shankar Musunuri and CFO Sanjay Subramanian at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Senior Research Analyst Ahu Demir, PhD joins Shankar and Sanjay to moderate a Q&A session.

Lineage Cell Therapeutics (LCTX) CEO Brian Culley at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Senior Research Analyst Ahu Demir, PhD joins Brian to moderate a Q&A session.

Jaguar Health (JAGX) CEO Lisa Conte at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Head of Healthcare Banking Nathan Cali joins Lisa to moderate a Q&A session.

Helius Medical Technologies (HSDT) CEO Dane Andreeff at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Senior Research Analyst Michael Kupinski joins Dane to moderate a Q&A session.

Genprex (GNPX) CEO Rodney Varner at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Senior Research Analyst Ahu Demir, PhD joins Rodney to moderate a Q&A session.

Eledon Pharmaceuticals (ELDN) CEO David-Alexandre Gros and CFO Jon Kuwahara at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Head of Healthcare Banking Nathan Cali joins David-Alexandre and Jon to moderate a Q&A session.

Cure Pharmaceutical (CURR) CEO Robert Davidson and CFO Michael Redard at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Senior Research Analyst Ahu Demir, PhD joins Robert and Michael to moderate a Q&A session.

Cocrystal Pharma (COCP) CEO Gary Wilcox at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Senior Research Analyst Ahu Demir, PhD joins Gary to moderate a Q&A session.

Citius Pharmaceuticals (CTXR) Executive Chairman Leonard Mazur at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Senior Research Analyst Ahu Demir, PhD joins Leonard to moderate a Q&A session.

Ceapro (CRPOF) CEO Gilles Gagnon at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Senior Research Analyst Ahu Demir, PhD joins Gilles to moderate a Q&A session.

Avivagen (VIVXF) CEO Kym Anthony at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Senior Research Analyst Joe Gomes joins Kym to moderate a Q&A session.